Retatrutide: How People Lost 71 POUNDS (New Clinical Data)

Retatrutide is Eli Lilly’s investigational triple agonist (GLP-1 + GIP + glucagon) and the newest “next-gen” metabolic drug everyone in the GLP-1 world is watching. In this video, Big Paul breaks down the new Phase 3 TRIUMPH-4 topline results in adults with obesity + knee osteoarthritis (without diabetes)—including the absolutely wild weight-loss numbers, the arthritis pain improvement, and the side effects people keep reporting.

🔗 For All My Info & Resources, Visit Link Tree: https://linktr.ee/anabolicbodybuilding

WARNING

========

The Video has been made available for entertainment and educational purposes only. I do not make any warranties to the accuracy, applicability, fitness, or completeness of the content.

The content is not intended to be a substitute for professional medical or legal advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health provider. Never disregard professional medical advice or delay in seeking it because of something you have seen on this channel.

I hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental, or other consequential damages arising directly or indirectly from any use of the content, which is provided as is, and without warranties.